K Shimokata Selected Research

Cisplatin (Platino)

4/2000

Synergistic effects of adenovirus expressing wild-type p53 on chemosensitivity of non-small cell lung cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

K Shimokata Research Topics

Disease

7	Lung Neoplasms (Lung Cancer) 12/2004 - 04/2000
6	Neoplasms (Cancer) 07/2001 - 04/2000
4	Asthma (Bronchial Asthma) 02/2009 - 04/2007
3	Inflammation (Inflammations) 02/2009 - 06/2003
2	Fibrosis (Cirrhosis) 06/2003 - 05/2000
2	Carcinogenesis 07/2001 - 05/2001
1	Myositis (Idiopathic Inflammatory Myopathies) 01/2008
1	Chronic Obstructive Pulmonary Disease (COPD) 06/2007
1	Eosinophilia 04/2007
1	Hyperplasia 04/2007
1	Disease Progression 06/2006
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2006
1	Brain Neoplasms (Brain Tumor) 12/2004
1	Wolff-Parkinson-White Syndrome (Wolf-Parkinson-White Syndrome) 08/2001
1	Malignant Mesothelioma 07/2001
1	Adenocarcinoma 07/2001
1	Mesothelioma 07/2001
1	Adenoma (Adenomas) 05/2001
1	Diffuse panbronchiolitis 03/2001
1	Uremia 02/2001
1	Leukopenia 12/2000
1	Diarrhea 12/2000
1	Diabetic Nephropathies (Diabetic Nephropathy) 05/2000
1	Chronic Kidney Failure (Chronic Renal Failure) 05/2000
1	Sclerosis 05/2000
1	Proteinuria 04/2000
1	Infections 04/2000
1	Hypersensitivity (Allergy) 04/2000
1	Glomerulonephritis 04/2000
1	Azotemia 04/2000

Drug/Important Bio-Agent (IBA)

3	Codon (Codons)IBA 07/2001 - 05/2000
2	Irinotecan (Camptosar)FDA LinkGeneric 12/2001 - 12/2000
2	Proteins (Proteins, Gene)FDA Link 07/2001 - 05/2001
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 02/2009
1	ProstaglandinsIBA 02/2009
1	Oxidants (Oxidizing Agents)IBA 02/2009
1	IsoprostanesIBA 02/2009
1	Tryptases (Tryptase)IBA 01/2008
1	PAR-2 ReceptorIBA 01/2008
1	Adrenergic Agents (Adrenergic Drugs)IBA 01/2008
1	Adenosine Triphosphate (ATP)IBA 06/2007
1	Methacholine Chloride (Methacholine)FDA Link 04/2007
1	Interleukin-5 (Interleukin 5)IBA 04/2007
1	CytokinesIBA 04/2007
1	AllergensIBA 04/2007
1	fasudil (AT 877)IBA 04/2007
1	ChemokinesIBA 04/2007
1	Interleukin-13IBA 04/2007
1	rho-Associated KinasesIBA 04/2007
1	Gefitinib (Iressa)FDA Link 06/2006
1	gadoteridol (Prohance)FDA Link 12/2004
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 06/2003
1	Carboplatin (JM8)FDA LinkGeneric 12/2001
1	beta CateninIBA 07/2001
1	Interferon-gamma (Interferon, gamma)IBA 06/2001
1	CD40 Ligand (CD40L)IBA 06/2001
1	Messenger RNA (mRNA)IBA 05/2001
1	Telomerase (Telomerase Reverse Transcriptase)IBA 05/2001
1	Urethane (Ethyl Carbamate)IBA 05/2001
1	Erythromycin (Erycette)FDA LinkGeneric 03/2001
1	Glutathione (Reduced Glutathione)IBA 02/2001
1	Glutathione Disulfide (GSSG)FDA LinkGeneric 02/2001
1	glutathionyl hemoglobinIBA 02/2001
1	DisulfidesIBA 02/2001
1	CreatinineIBA 05/2000
1	AST 120IBA 05/2000
1	IndicanIBA 05/2000
1	Insulin (Novolin)FDA Link 05/2000
1	NucleotidesIBA 05/2000
1	Tissue Inhibitor of Metalloproteinase-1IBA 05/2000
1	Thymidine KinaseIBA 04/2000
1	Fc Receptors (Fc Receptor)IBA 04/2000
1	Paclitaxel (Taxol)FDA LinkGeneric 04/2000
1	Immunoglobulin G (IgG)IBA 04/2000
1	antiglomerular basement membrane antibodyIBA 04/2000
1	GuanosineIBA 04/2000
1	Etoposide (VP 16)FDA LinkGeneric 04/2000
1	Pharmaceutical PreparationsIBA 04/2000
1	DNA (Deoxyribonucleic Acid)IBA 04/2000
1	Complement System Proteins (Complement)IBA 04/2000
1	Cisplatin (Platino)FDA LinkGeneric 04/2000
1	Docetaxel (Taxotere)FDA Link 04/2000
1	9- ((cis- 1,2- bis(hydroxymethyl)cycloprop- 1- yl)methyl)guanineIBA 04/2000
1	Ganciclovir (Cytovene)FDA LinkGeneric 04/2000

Therapy/Procedure

1	Oral Administration 04/2007
1	Therapeutics 06/2006
1	Catheter Ablation 08/2001
1	Continuous Ambulatory Peritoneal Dialysis (CAPD) 02/2001
1	Renal Dialysis (Hemodialysis) 02/2001
1	Intravenous Injections 04/2000